Challenges of Diagnosing Acute HIV-1 Subtype C Infection in African Women: Performance of a Clinical Algorithm and the Need for Point-of-Care Nucleic-Acid Based Testing

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Mlisana, Koleka ^a,b,c   Sobieszczyk, Magdalena ^d   Werner, Lise ^a   Feinstein, Addi ^d   van Loggerenberg, Francois ^a   Naicker, Nivashnee ^a   Williamson, Carolyn ^a,e   Garrett, Nigel ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; VIRUS ANTIBODY; VIRUS RNA;

ACUTE HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C INFECTION; ADULT; AGE; ALGORITHM; ANOREXIA; ANTIBODY DETECTION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ETHNIC GROUP; FEMALE; GENITAL ULCER; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; RASH; RISK ASSESSMENT; RNA ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SORE THROAT; SOUTH AFRICAN; SYMPTOM; VAGINA DISCHARGE; VIRUS LOAD; WEIGHT REDUCTION; GENETICS; HIV INFECTIONS; HOSPITAL INFORMATION SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MASS SCREENING; MIDDLE AGED; MOLECULAR DIAGNOSIS; REPRODUCIBILITY; RISK; SOUTH AFRICA; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ALGORITHMS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MASS SCREENING; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; RISK; SOUTH AFRICA; YOUNG ADULT;

EID: 84877004356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062928     Document Type: Article

References (43)

1. UNAIDS (2010) Report on the global HIV/AIDS epidemic 2010. UNAIDS.
2. Boily MC, Baggaley RF, Wang L, Masse B, White RG, et al. (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9: 118-129.
3. Cohen MS, Shaw GM, McMichael AJ, Haynes BF, (2011) Acute HIV-1 Infection. N Engl J Med 364: 1943-1954.
4. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191: 1403-1409.
5. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, et al. (2011) The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 378: 256-268.
6. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357: 1149-1153.
7. Pilcher CD, Joaki G, Hoffman IF, Martinson FE, Mapanje C, et al. (2007) Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 21: 1723-1730.
8. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342: 921-929.
9. Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, et al. (2012) Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 205: 358-365.
10. Fidler S (2011) The effect of short-course antiretroviral therapy in primary HIV infection: final results from an international randomised controlled trial; SPARTAC. 6th International AIDS Society Conference on HIV pathogenesis, treatment and prevention. Rome, Italy.
11. Grijsen ML, Steingrover R, Wit FW, Jurriaans S, Verbon A, et al. (2012) No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. PLoS Med 9: e1001196.
12. Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, et al. (2012) The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis 205: 87-96.
13. Bell SK, Little SJ, Rosenberg ES, (2010) Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis 202Suppl 2: S278-288.
14. Chun TW, Justement JS, Moir S, Hallahan CW, Maenza J, et al. (2007) Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis 195: 1762-1764.
15. Koopman JS, Jacquez JA, Welch GW, Simon CP, Foxman B, et al. (1997) The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 14: 249-258.
16. Moir S, Buckner CM, Ho J, Wang W, Chen J, et al. (2010) B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood 116: 5571-5579.
17. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, et al. (2000) Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
18. Lavreys L, Thompson ML, Martin HL Jr, Mandaliya K, Ndinya-Achola JO, et al. (2000) Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis 30: 486-490.
19. Powers KA, Miller WC, Pilcher CD, Mapanje C, Martinson FE, et al. (2007) Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS 21: 2237-2242.
20. Kahn JO, Walker BD, (1998) Acute human immunodeficiency virus type 1 infection. N Engl J Med 339: 33-39.
21. Cohen MS, Gay CL, Busch MP, Hecht FM, (2010) The detection of acute HIV infection. J Infect Dis 202Suppl 2: S270-277.
22. Lindback S, Thorstensson R, Karlsson AC, von Sydow M, Flamholc L, et al. (2000) Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 14: 2333-2339.
23. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al. (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719-3733.
24. Rosenberg NE, Kamanga G, Phiri S, Nsona D, Pettifor A, et al. (2012) Detection of acute HIV infection: a field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J Infect Dis 205: 528-534.
25. van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, et al. (2008) Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS ONE 3: e1954.
26. Francois van Loggerenberg AAD, Magdalena E. Sobieszczyk, Lise Werner, Anneke Grobler, and Koleka Mlisana, for the CAPRISA 002 Acute Infection Study Team (2012) HIV prevention in high-risk women in South Africa: Condom use and the need for change.
27. Kaufmann GR, Cunningham P, Zaunders J, Law M, Vizzard J, et al. (1999) Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection. Sydney Primary HIV Infection Study Group. J Acquir Immune Defic Syndr 22: 437-444.
28. Kaufmann GR, Duncombe C, Zaunders J, Cunningham P, Cooper D, (1998) Primary HIV-1 infection: a review of clinical manifestations, immunologic and virologic changes. AIDS Patient Care STDS 12: 759-767.
29. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, et al. (2000) Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 181: 872-880.
30. Niu MT, Stein DS, Schnittman SM, (1993) Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis 168: 1490-1501.
31. Schacker T, Collier AC, Hughes J, Shea T, Corey L, (1996) Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125: 257-264.
32. Tindall B, Barker S, Donovan B, Barnes T, Roberts J, et al. (1988) Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 148: 945-949.
33. Pilcher CD, Price MA, Hoffman IF, Galvin S, Martinson FE, et al. (2004) Frequent detection of acute primary HIV infection in men in Malawi. AIDS 18: 517-524.
34. Serna-Bolea C, Munoz J, Almeida JM, Nhacolo A, Letang E, et al. (2010) High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS 24: 603-608.
35. Ndung'u T, Sepako E, McLane MF, Chand F, Bedi K, et al. (2006) HIV-1 subtype C in vitro growth and coreceptor utilization. Virology 347: 247-260.
36. Welz T, Hosegood V, Jaffar S, Batzing-Feigenbaum J, Herbst K, et al. (2007) Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS 21: 1467-1472.
37. Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, et al. (1995) Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 9: 305-310.
38. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, et al. (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170.
39. Vanhems P, Hirschel B, Phillips AN, Cooper DA, Vizzard J, et al. (2000) Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis 182: 334-337.
40. Ghosn J, Deveau C, Chaix ML, Goujard C, Galimand J, et al. (2010) Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort. J Antimicrob Chemother 65: 741-748.
41. Lavreys L, Baeten JM, Chohan V, McClelland RS, Hassan WM, et al. (2006) Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 42: 1333-1339.
42. Lavreys L, Baeten JM, Overbaugh J, Panteleeff DD, Chohan BH, et al. (2002) Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. Clin Infect Dis 35: 77-81.
43. Cohen T, Corbett EL, (2011) Test and treat in HIV: success could depend on rapid detection. Lancet 378: 204-206.